發(fā)布時間：2018-01-30 12:55

  本文關鍵詞： 體外膜肺氧合 重癥醫(yī)學 ARDS 治療效果　出處：《現(xiàn)代預防醫(yī)學》2015年01期 　論文類型：期刊論文

【摘要】：目的評估體外膜肺氧合對重癥患者的治療效果,為今后臨床救治重癥ARDS患者提供依據(jù)。方法選擇2008年1月-2013年3月至我院ICU救治的患者中,由于呼吸窘迫綜合癥機械通氣效果不佳進行ECMO支持治療的重癥患者21例作為研究對象。所有患者均采用靜脈-靜脈(V-V)體外膜肺流轉模式,同時采用保護性肺通氣策略,監(jiān)測中心靜脈壓。評估治療前后患者血氣指標、APACHEⅡ評分、SOFA評分及患者的轉歸。結果治療前患者平均Sa O2為0.81±0.03、Pa CO2為47.3±6.9,p H值為7.10±0.14,經(jīng)ECMO治療后的三項指標分別為0.98±0.02、33.5±4.6及7.42±0.08,與治療前相比差異均具有統(tǒng)計學意義(P0.001);治療前患者APACHEⅡ評分為17.1±7.3,SOFA評分為7.5±2.2,經(jīng)過ECMO治療后APACHEⅡ評分為6.8±3.0、SOFA評分為6.0±1.8,治療前后相比差異具有統(tǒng)計學意義(P0.05)。在21例接受治療的患者中,2例死亡,其余19例均順利出院,死亡率為9.52%。結論 ECMO能減輕重癥患者心肺負荷,改善患者缺氧癥狀,促進心肺的恢復,減少有關并發(fā)癥的發(fā)生。
[Abstract]:Objective to evaluate the effect of extracorporeal membrane oxygenation on severe patients. Methods from January 2008 to March 2013, we selected the patients who were treated with ICU in our hospital from January 2008 to March 2013. Twenty-one patients with severe respiratory distress syndrome who were treated with ECMO support because of poor mechanical ventilation were studied. All patients were treated with IV-VV extracorporeal membrane pulmonary flow model. At the same time, the protective lung ventilation strategy was used to monitor the central venous pressure and to evaluate the blood gas index and Apache 鈪，

本文編號：1476288